Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 18/7/2018
SIETES contiene 92409 citas

 
 
 1 a 20 de 907 siguiente >>
Presentar resultados
Seleccionar todas
2.Enlace a cita original Cita con resumen
Lembke A, Papac J, Humphreys K. Our other prescription drug problem. N Engl J Med 2018;378:22 de febrero. [Ref.ID 102557]
3. Cita con resumen
Johansen ME. Gabapentinoid use in the United States 2002 through 2015. JAMA Intern Med 2018:2 de enero. [Ref.ID 102440]
4. Cita con resumen
Henriksen DP, Davidsen JR, Laursen CB, Christiansen A, Damkier P, Hallas J, Pottegård A. Montelukast use — A 19-year nationwide drug utilisation study. Eur J Clin Pharmacol 2017;73:1297-304. [Ref.ID 102083]
5. Cita con resumen
Schuchat A, Houry D, Guy Jr GP. New data on opioid use and prescribing in the United States. JAMA 2017;318:425-6. [Ref.ID 102055]
6. Cita con resumen
Taylor LG, Bird ST, Sahin L, Tassinari MS, Greene P, Reichman ME, Andrade SE, Haffenreffer K, Toh S. Antiemetic use among pregnant women in the United States: the escalating use of ondansetron. Pharmacoepidemiol Drug Saf 2017;26:592-6. [Ref.ID 101960]
7. Cita con resumen
Schröder C, Dörks M, Kollhorst B, Blenk T, Dittmann RW, Garbe E, Riedel O. Outpatient antidepressant drug use in children and adolescents in Germany between 2004 and 2011. Pharmacoepidemiol Drug Saf 2017;26:170-9. [Ref.ID 101952]
8. Cita con resumen
Obach M, Lopez P, Catalan A. Tratamiento farmacológico de la enfermedad de Alzheimer en la población de Catalu˜na. Med Clin (Barc) 2017;149:86-7. [Ref.ID 101905]
9. Cita con resumen
Guy Jr GP, Zhang K, Bohm MK, Lewis B, Young R, Murphy LB, Dowell D. Vital Signs: changes in opioid prescribing in the United States, 2006–2015. MMWR Morb Mortal Wkly Rep 2017;66:697-704. [Ref.ID 101665]
11. Cita con resumen
Greenway T, Ross JS. US drug marketing: how does promotion correspond with health value?. BMJ 2017;357:j1855. [Ref.ID 101571]
12. Cita con resumen
13. Cita con resumen
Anónimo. Global spending on prescription drugs to hit $1.5 trillion by 2021. DIA Daily 2016:1. [Ref.ID 100994]
14. Cita con resumen
Baftiu A, Landmark CJ, Rusten IR, Feet SA, Johannessen SI, Larsson PG. Changes in utilisation of antiepileptic drugs in epilepsy and non-epilepsy disorders - A pharmacoepidemiological study and clinical implications. Eur J Clin Pharmacol 2016;72:1245-54. [Ref.ID 100799]
15. Cita con resumen
Anónimo. Antidepressants show greatest increase in number of prescription items dispensed. NHS Digital 2016:5 de julio. [Ref.ID 100635]
16. Cita con resumen
Anónimo. Prescriptions dispensed in the community, statistics for England - 2005-2015. NHS Digital 2016:5 de julio. [Ref.ID 100632]
17. Cita con resumen
Kesselheim AS, Avorn J, Sarpatwari A. The high cost of prescription drugs in the United States: origins and prospects for reform. JAMA 2016;316:858-71. [Ref.ID 100589]
18. Cita con resumen
Ghinea N, Lipworth W, Kerridge I. Propaganda or the cost of innovation? Challenging the high price of new drugs. BMJ 2016;352:i1284. [Ref.ID 100333]
19. Cita con resumen
Dyer C. GSK is fined £38m for delaying generic paroxetine. BMJ 2016;352:i917. [Ref.ID 100059]
20. Cita con resumen
Zhang F, Mamtani R, Scott FI, Goldberg DS, Haynes K, Lewis JD. Increasing use of prescription drugs in the United Kingdom. Pharmacoepidemiol Drug Saf 2016;25:628-36. [Ref.ID 100019]
Seleccionar todas
 
 1 a 20 de 907 siguiente >>